Artemisia atrovirens

Artemisia atrovirens · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Artemisia atrovirens is a botanical species currently being investigated for its potential therapeutic applications in managing cervical cancer. Researchers are focusing on specific bioactive components, such as Artematrolide A, to understand their anti-tumor properties. Various preparation methods, including the use of EtOAc fractions and EtOH extracts, are employed to isolate these medicinal compounds. Additionally, the powdered form of the plant is utilized in experimental models to evaluate its efficacy against malignant cells. This ongoing study aims to uncover how the chemical constituents of this plant can contribute to advanced cancer treatments.

Quick facts
Synonyms
Not available
Common names
Not available
Family
Asteraceae
Distribution
Not available
Plant Parts
Not available

Classification

Taxonomy

Artemisia atrovirens belongs to the vast kingdom Plantae, marking its place among the diverse life forms on Earth. Within this kingdom, it is classified under the class Equisetopsida, representing a significant lineage of flowering plants. This species is further categorized into the order Asterales, which provides a framework for its evolutionary development. It holds a specialized position within the genus Artemisia, a group known for its unique botanical characteristics. Finally, it is a recognized member of the Asteraceae family, connecting it to the widespread and diverse daisy family.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Asterales
Family Asteraceae
Genus Artemisia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Artemisia atrovirens exhibits a widespread distribution that spans across several key regions of Asia. Within the temperate zones of China, this plant can be found throughout the North-Central, South-Central, and Southeast territories. Its presence extends beyond these northern reaches into the more tropical climates of the Indo-China peninsula. Specifically, it has established itself within the diverse landscapes of Thailand. This broad geographical range highlights the adaptability of the species across varying Asian ecosystems.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Artemisia atrovirens is characterized by its distinct growth form as a herbaceous plant. This species is entirely self-supporting, maintaining its structure without the need for external assistance.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Conditions

Artemisia atrovirens exhibits significant therapeutic potential through its ability to treat various hepatoma cell lines. Specifically, extracts and isolated compounds from the plant demonstrate potent cytotoxicity against the HepG2 and Huh7 cell lines. Research also indicates that the plant's derivatives, such as artematrolide A, are effective in treating the SMMC-7721 hepatoma cell line. Furthermore, the bioactive constituents of Artemisia atrovirens show promise in treating cervical cancer by inhibiting cell proliferation and inducing apoptosis. These combined effects highlight the plant's broad efficacy in targeting multiple specific cancer cell models.

Preparations

Artemisia atrovirens serves as the source material for several distinct preparations used in pharmacological research. The plant is processed into a powdered form, which can be authenticated using high-resolution melting technology. Researchers have also utilized an EtOH extract of the plant, which demonstrates significant cytotoxicity against human hepatoma cell lines. Furthermore, an EtOAc fraction prepared from the plant has been used in bioactivity-guided fractionation to isolate various guaianolide dimers. Finally, the specific compound Artematrolide A is isolated from Artemisia atrovirens to study its inhibitory effects on cervical cancer cell proliferation.

Parts used